AbbVie
ABBV
#28
Rank
$306.01 B
Marketcap
$172.99
Share price
0.76%
Change (1 day)
3.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of April 2025 (TTM): 5.43

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 91.0. At the end of 2024 the company had a P/S ratio of 5.58.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.97-63.67%๐Ÿ‡บ๐Ÿ‡ธ USA
2.07-61.82%๐Ÿ‡บ๐Ÿ‡ธ USA
16.7 208.27%๐Ÿ‡บ๐Ÿ‡ธ USA
4.46-17.89%๐Ÿ‡บ๐Ÿ‡ธ USA
4.53-16.56%๐Ÿ‡บ๐Ÿ‡ธ USA
1.79-66.97%๐Ÿ‡บ๐Ÿ‡ธ USA
1.81-66.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
3.88-28.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.26-21.60%๐Ÿ‡บ๐Ÿ‡ธ USA